Categories Earnings, Technology

Alteryx (AYX) pulls off another massive beat in Q4, stock gains

Data analytics firm Alteryx (NYSE: AYX) reported a profit of 64 cents per share for the fourth quarter of 2019, compared to 32 cents per share it reported last year. Meanwhile, revenues of $156.5 million were 75% higher year-over-year. The results were stronger than what the street anticipated. 

The results also came above the targets set by the firm during the previous earnings announcement. The Irvine, California-based company had last quarter projected Q4 earnings of 27-30 cents per share on revenues of $128-131 million. 

alteryx Q4 2019 earnings

AYX shares gained 3.2% immediately following the announcement. The stock, which has gained 39% since the beginning of this year, has soared over 9 times since its IPO three years ago. 

Historically, Alteryx is often seen giving conservative guidance, which it beats handsomely when the announcement is made.  

CFO Kevin Rubin has earlier told AlphaStreet that EPS is not the primary focus from an investor perspective, adding that shareholders understand the enormous opportunities in the global data analytics industry.  

READ: Interview with Alteryx CFO Kevin Rubin

Alteryx operates in a high-growth data analytics industry and offers unique products that are accessible to both professionals and non-coders as well. Its growth has been driven by robust customer addition and an envious reach into the Global 2000. Alteryx ended the quarter with 6,087 customers, a 30% increase from the fourth quarter of 2018, reflecting net new addition of 474 customers.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top